Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 1Rectal Neoplasms 1Plasmacytoma 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Margins of Excision 1Homologous Recombination Deficient Solid Tumors 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Microscopy, Confocal 2Indocyanine Green 2Ultrasonography 1Tumor Burden 1Sunitinib 1Simvastatin 1Radiosurgery 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Narrow Band Imaging 1Mastectomy, Segmental 1IFL protocol 1Gastrectomy 1Folfox protocol 1Everolimus 1Esophagectomy 1Endoscopic Mucosal Resection 1Drug Delivery Systems 1Drug Combinations 1Dermoscopy 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Margins of Excision × Drug Combinations × Clear all
NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting
364 enrolled
Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡